Researchers studying a common form of epilepsy have made an important discovery about a process within the brain's hippocampus that appears to modulate seizure activity and suggests a possible new ...

Epilepsy is already represented in Jazz Pharmaceuticals’ portfolio by Epidiolex, a drug that treats seizures caused by three rare types of this brain disorder. Epilepsies have many drivers, and Jazz ...

In what could one day become a new treatment for epilepsy, researchers at UC San Francisco, UC Santa Cruz and UC Berkeley have used pulses of light to prevent seizure-like activity in neurons.The ...

Smart Monitoring for People with Epilepsy Start-up project at the University Hospital Bonn and University of Bonn to receive €2.7 million in GO-Bio next funding from the BMFTR.

Epilepsy is best known for seizures, but many people with the condition also experience much more frequent and subtler disruptions. These brief bursts of abnormal brain activity, called interictal ...

Video: Explains in more detail the different receptors affected by epilepsy. Researchers at the University of Copenhagen were able to pinpoint specific subtypes of nerve cells and neural circuits ...

About This EventXenon Pharmaceuticals Inc (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing ...

A review in Science looked at the oscillatory biology of sleep and how disruptions are linked with dementia risk. Using artificial intelligence (AI) and MRI data, a novel framework revealed how the ...

Electroencephalography, or EEG, was invented 100 years ago. In the years since the invention of this device to monitor brain electricity, it has had an incredible impact on how scientists study the ...

Childhood epilepsy affects roughly 4% of the pediatric population, and there are many different types of epilepsy and seizure frequency and intensity. 20% of patients have intractable epilepsy, which ...

Sales of Biohaven Pharmaceuticals’ lead migraine medication continue to grow, and the drug developer is now putting some of that cash to work in a pair of deals that expand its scope in neuroscience.

The CAMC Foundation has announced a $5 million philanthropic gift from the Elliot Family Foundation to establish the Vandalia ...